Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.
about
Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune SuppressionExtracellular Vesicles in Physiology, Pathology, and Therapy of the Immune and Central Nervous System, with Focus on Extracellular Vesicles Derived from Mesenchymal Stem Cells as Therapeutic ToolsResearch Progress on Regulatory T Cells in Acute Kidney InjuryGalectins: guardians of eutherian pregnancy at the maternal-fetal interfaceRegulation generation: the suppressive functions of human regulatory T cellsGalectin-1 research in T cell immunity: past, present and futureRegulatory T cells: Mechanisms of suppression and impairment in autoimmune liver diseaseInteraction between natural killer cells and regulatory T cells: perspectives for immunotherapyInnate immunity, decidual cells, and preeclampsiaRegulatory T-cells: diverse phenotypes integral to immune homeostasis and suppressionCritical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infectionGalectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and NeoplasiaInflammation and skeletal metastasisProteomic analysis of excretory-secretory products of Heligmosomoides polygyrus assessed with next-generation sequencing transcriptomic informationProteome analysis of distinct developmental stages of human natural killer (NK) cellsThe protein tyrosine phosphatase SHP-1 modulates the suppressive activity of regulatory T cellsDevelopment of a cross-platform biomarker signature to detect renal transplant tolerance in humans.MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells.Differential expression of immunomodulatory galectin-1 in peripheral leukocytes and adult tissues and its cytosolic organization in striated muscle.In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia.Presence of FOXP3(+)Treg cells is correlated with colorectal cancer progressionMLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.Suppression of autoimmune diabetes by soluble galectin-1Gimme shelter: the immune system during pregnancy.Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation.Galatrox is a C-type lectin in Bothrops atrox snake venom that selectively binds LacNAc-terminated glycans and can induce acute inflammation.New roads open up for implementing immunotherapy in mesothelioma.Increased T regulatory cells are associated with adverse clinical features and predict progression in multiple myeloma.Regulatory T cell-derived exosomes: possible therapeutic and diagnostic tools in transplantationPolyclonal adaptive regulatory CD4 cells that can reverse type I diabetes become oligoclonal long-term protective memory cellsA glycobiology review: carbohydrates, lectins and implications in cancer therapeuticsTregs utilize beta-galactoside-binding protein to transiently inhibit PI3K/p21ras activity of human CD8+ T cells to block their TCR-mediated ERK activity and proliferationGalectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.Natural regulatory T cells in autoimmunity.T-cell growth, cell surface organization, and the galectin-glycoprotein lattice.Characterizing the glycome of the mammalian immune system.Dendritic cell control of tolerogenic responses.Fingerprinting of galectins in normal, P. aeruginosa-infected, and chemically burned mouse corneasTransplantation tolerance: Clinical potential of regulatory T cells.Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.
P2860
Q26744626-ACD9E1EE-C2A1-49CE-889D-1FB729F98BD7Q26747560-DADB11B0-54C1-45F4-9045-66CD4CEA3BC6Q26798141-67D25162-E2F1-4C76-986E-6B68D581F2A6Q26823092-4C0612C3-400C-4373-8ECB-97B4CBA286C0Q26823216-CC9D5AE3-3328-447C-B40B-342DCC659DAEQ26825120-58075B1D-5141-4A96-905A-B6132811B794Q26827787-3E884305-FC37-4F12-94BC-4BF93021AC7EQ27008625-072DC8D2-9D47-47E9-A0C7-CF916B7E94A8Q27014127-6AEBAD8B-DDD3-4E07-A8AC-16845BE233A6Q27022973-7AFDDDE1-C3FF-4988-A1A0-3134AE9F6BB3Q27318086-1D95C7C6-56E2-429D-A80A-DE9B0C2F0FAAQ28081459-0F61CF0F-B1C6-450E-BEDC-C2DB665C48A7Q28396089-FDF737E2-8CCC-49EC-B0DD-42F9557E4841Q28477611-5539A60D-5BEC-4C00-91D1-89128C946CE9Q28704450-94F9AAA3-D024-4D29-B304-5FA7FDBBDE59Q30429749-95ED259C-A3F2-40B7-AA8C-CADBABA55178Q33882838-93CCE097-C4CF-4673-8856-2114CE0B7703Q33922230-D86BB8F6-D16D-44FD-B329-8E2C310CE618Q33979019-5C90E713-E934-4942-8147-274B08B8E012Q33997187-2AB4E655-6EEC-4046-BD11-02F0FBB2A4D0Q34042234-250116A9-0AB7-43E7-B72E-F546A5AEC75CQ34060270-E411509A-BEB6-4AA8-9381-92D4F0A2A07AQ34087128-9E004B9B-D1B4-461F-B466-09DEB565D1FDQ34177939-8ADABCDE-4586-434C-AAE7-E3CBC1AE2C39Q34192497-95158930-57DC-4D4E-B983-BE68DF6A4FB8Q34273347-F938A278-B978-45DB-8572-0BA67B66B7A4Q34331993-32A704D5-C44B-405F-82EF-3A31D792060AQ34447864-85B2745C-B5DF-4A46-9B5E-BEAD7B8D9A53Q34454926-A3CB6BC5-40BF-4965-A503-E970677C8717Q34512471-8DE6ACE7-4D85-48B9-ACE4-CA0A5B728B8EQ34524965-6C2E70E6-8801-45D0-8122-2DE0EA7ABCC4Q34608828-9C120C1F-D910-4BC8-8A2B-89D1838F54BCQ34619694-D17C7CF2-57D2-41AC-BEA8-531D2B92E134Q34676250-B667E308-D4CC-4F24-B380-86448FE8A882Q34691040-436B98F4-2010-49DE-9E13-2A7B44792795Q34813256-8F508AB8-DCC6-476F-8FBE-F9285C762040Q34982085-F083CF90-7959-4422-8395-40BA02BD67F2Q34999835-30152DDA-4CFE-4151-98F4-0DD8B3A8820BQ35107006-2CD6388F-5831-41B5-8FF8-762DA413E7ABQ35161285-28B27D08-5858-4708-A4E5-3EF94F55D08E
P2860
Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.
@en
Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.
@nl
type
label
Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.
@en
Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.
@nl
prefLabel
Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.
@en
Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.
@nl
P2093
P1433
P1476
Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.
@en
P2093
Chung-Ching Chu
Eva Cernuda-Morollón
Marina I Garín
Robert I Lechler
Robin Wait
P304
P356
10.1182/BLOOD-2006-04-016451
P407
P577
2006-11-16T00:00:00Z